Center for Scientific Review; Notice of Closed Meetings, 57681-57682 [2021-22555]
Download as PDF
<![CDATA[
57681
Federal Register / Vol. 86, No. 198 / Monday, October 18, 2021 / Notices
Comments on the ICR must be
received on or before December 17,
2021.
ADDRESSES: Submit your comments to
sagal.musa@hhs.gov or by calling (202)
205–2634.
FOR FURTHER INFORMATION CONTACT:
When submitting comments or
requesting information, please include
the document identifier 4040–0019–
New–60D and project title for reference,
to Sagal Musa, email: sagal.musa@
hhs.gov, or call (202) 205–2634 the
Reports Clearance Officer.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
DATES:
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: Project
Abstract Summary.
Type of Collection: Renewal.
OMB No.: 4040–0019.
Abstract
The Project Abstract Summary form
provides the Federal grant-making
agencies an alternative to the Standard
Form 424 data set and form. Agencies
may use Project Abstract Summary form
for grant programs not required to
collect all the data that is required on
the SF–424 core data set and form.
Project Abstract Summary form is used
by organizations to apply for Federal
financial assistance in the form of
grants. This form is evaluated by
Federal agencies as part of the overall
grant application. This IC expires on
February 28, 2022. Grants.gov seeks a
three-year clearance of these collections.
ANNUALIZED BURDEN HOUR TABLE
Project Abstract Summary ................
Grant applicants ...............................
3,467
1
1
3,467
Total ...........................................
...........................................................
3,467
........................
1
3,467
[FR Doc. 2021–22647 Filed 10–15–21; 8:45 am]
BILLING CODE 4151–AE–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Neurological Injuries and Disorders.
Date: November 8, 2021.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
18:28 Oct 15, 2021
Jkt 256001
Number of
respondents
Average
burden per
response
Respondents
(if necessary)
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
jspears on DSK121TN23PROD with NOTICES1
Number of
responses per
respondents
Forms
(if necessary)
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jordan Matthew Moore,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1002A1,
Bethesda, MD 20892, (301) 451–0293,
moorejom@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Cerebrovascular Disorders.
Date: November 10, 2021.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jordan Matthew Moore,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1002A1,
Bethesda, MD 20892, (301) 451–0293,
moorejom@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Transplantation and Autoimmunity.
Date: November 10, 2021.
Time: 12:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shiv A. Prasad, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5220,
MSC 7852, Bethesda, MD 20892, 301–443–
5779, prasads@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Infectious, Foodborne and
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Total burden
hours
Waterborne Disease Diagnostics and Methods
in Microbial Sterilization and Disinfection.
Date: November 15–16, 2021.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Gagan Pandya, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, RM 3200,
MSC 7808, Bethesda, MD 20892, (301) 435–
1167, pandyaga@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–19–
367: Maximizing Investigators’ Research
Award (R35—Clinical Trial Optional).
Date: November 18–19, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: David Balasundaram,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5189,
MSC 7840, Bethesda, MD 20892, 301–435–
1022, balasundaramd@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Skeletal and Dental Biology and
Tissue Engineering.
Date: November 18, 2021.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
E:\FR\FM\18OCN1.SGM
18OCN1
57682
Federal Register / Vol. 86, No. 198 / Monday, October 18, 2021 / Notices
Contact Person: Chee Lim, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4128, Bethesda, MD 20892,
(301) 435–1850, limc4@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 12, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: October 13, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–22643 Filed 10–15–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Meeting
[FR Doc. 2021–22555 Filed 10–15–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
jspears on DSK121TN23PROD with NOTICES1
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIDA
and NIAAA Institutional Research Training
Grant (T32/T35) Review Panel.
Date: November 10–12, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Sindhu Kizhakke
Madathil, Ph.D., Scientific Review Officer,
Scientific Review Branch, National Institute
on Drug Abuse, NIH, 301 North Stonestreet
Avenue, MSC 6021, Bethesda, MD 20892,
(301) 827–5702, sindhu.kizhakkemadathil@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
VerDate Sep<11>2014
18:28 Oct 15, 2021
Jkt 256001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors, NIA.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended for the review, discussion,
and evaluation of individual intramural
programs and projects conducted by the
NATIONAL INSTITUTE ON AGING,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, NIA.
Date: October 19–21, 2021.
Closed: October 19, 2021, 9:00 a.m. to 9:45
a.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor,
Conference Room 03C227, 251 Bayview
Boulevard, Baltimore, MD 21224 (Virtual
Meeting).
Open: October 19, 2021, 9:45 a.m. to 12:45
p.m.
Agenda: Committee discussion, individual
presentations, laboratory overview.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor,
Conference Room 03C227, 251 Bayview
Boulevard, Baltimore, MD 21224 (Virtual
Meeting).
Closed: October 19, 2021, 12:45 p.m. to
1:30 p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor,
Conference Room 03C227, 251 Bayview
Boulevard, Baltimore, MD 21224 (Virtual
Meeting).
Open: October 19, 2021, 1:30 p.m. to 3:30
p.m.
Agenda: Committee discussion, individual
presentations, laboratory overview.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor,
Conference Room 03C227, 251 Bayview
Boulevard, Baltimore, MD 21224 (Virtual
Meeting).
Closed: October 19, 2021, 3:30 p.m. to 5:30
p.m.
Agenda: To review and evaluate committee
discussion, individual presentations,
laboratory overview.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor,
Conference Room 03C227, 251 Bayview
Boulevard, Baltimore, MD 21224 (Virtual
Meeting).
Closed: October 20, 2021, 9:00 a.m. to 9:15
a.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor,
Conference Room 03C227, 251 Bayview
Boulevard, Baltimore, MD 21224 (Virtual
Meeting).
Open: October 20, 2021, 9:15 a.m. to 10:45
a.m.
Agenda: Committee discussion, individual
presentations, laboratory overview.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor,
Conference Room 03C227, 251 Bayview
Boulevard, Baltimore, MD 21224 (Virtual
Meeting).
Closed: October 20, 2021, 10:45 a.m. to
3:00 p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor,
Conference Room 03C227, 251 Bayview
Boulevard, Baltimore, MD 21224 (Virtual
Meeting).
Closed: October 21, 2021, 9:00 a.m. to 9:15
a.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor,
Conference Room 03C227, 251 Bayview
Boulevard, Baltimore, MD 21224 (Virtual
Meeting).
Open: October 21, 2021, 9:15 a.m. to 10:45
a.m.
Agenda: Committee discussion, individual
presentations, laboratory overview.
Place: National Institute on Aging,
Biomedical Research Center, 3rd Floor,
Conference Room 03C227, 251 Bayview
Boulevard, Baltimore, MD 21224 (Virtual
Meeting).
Closed: October 21, 2021, 10:45 a.m. to
12:30 p.m.
Agenda: To review and evaluate committee
discussion, individual presentations,
laboratory overview.
E:\FR\FM\18OCN1.SGM
18OCN1
]]>Agencies
[Federal Register Volume 86, Number 198 (Monday, October 18, 2021)]
[Notices]
[Pages 57681-57682]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-22555]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Topics in Neurological Injuries and Disorders.
Date: November 8, 2021.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jordan Matthew Moore, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1002A1, Bethesda, MD 20892, (301)
451-0293, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Topics in Cerebrovascular Disorders.
Date: November 10, 2021.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jordan Matthew Moore, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1002A1, Bethesda, MD 20892, (301)
451-0293, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Transplantation and Autoimmunity.
Date: November 10, 2021.
Time: 12:00 p.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shiv A. Prasad, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5220, MSC 7852, Bethesda, MD
20892, 301-443-5779, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Infectious, Foodborne and Waterborne Disease
Diagnostics and Methods in Microbial Sterilization and Disinfection.
Date: November 15-16, 2021.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Gagan Pandya, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, RM 3200, MSC 7808, Bethesda, MD 20892, (301) 435-
1167, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-19-367: Maximizing Investigators' Research Award (R35--
Clinical Trial Optional).
Date: November 18-19, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: David Balasundaram, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5189, MSC 7840, Bethesda, MD
20892, 301-435-1022, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Skeletal and Dental Biology and Tissue
Engineering.
Date: November 18, 2021.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
[[Page 57682]]
Contact Person: Chee Lim, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4128, Bethesda, MD 20892, (301) 435-1850,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 12, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-22555 Filed 10-15-21; 8:45 am]
BILLING CODE 4140-01-P
